New drug ENX-104 tested in healthy volunteers for safety and brain activity
NCT ID NCT07253272
First seen Jan 07, 2026 · Last updated May 14, 2026 · Updated 14 times
Summary
This early-stage study tested a single dose of ENX-104 in 10 healthy volunteers to see how safe it is, how much of the drug reaches the brain, and how long it stays in the body. Researchers used PET scans to measure the drug's effect on brain receptors. The study is complete and focused on gathering basic safety and drug behavior information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel London EPCU
London, Middlesex, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.